NOTE
5 - STOCK BASED COMPENSATION
|
A. |
The table below depicts the number of options granted to such
employee: |
SCHEDULE
OF NUMBER OF OPTIONS GRANTED
| |
options | | |
in
USD | |
| |
Three
months ended March 31, 2023 | |
| |
Number
of | | |
Weighted
average exercise price | |
| |
options | | |
in
USD | |
| |
| | |
| |
Options
outstanding at January 1, 2023 | |
| 10,846,284 | | |
$ | 0.0001 | |
Options
granted during the period *) | |
| 1,859,776 | | |
$ | 0.0001 | |
Options
outstanding at the end of period | |
| 12,706,060 | | |
$ | 0.0001 | |
Options
exercisable at the end of period | |
| 9,510,407 | | |
$ | 0.0001 | |
|
B. |
The estimated fair values
of the options granted to directors and employees were measured using Black and Scholes Model based on the following
assumptions: |
SCHEDULE
OF FAIR VALUE OF OPTIONS
Grant date | |
July
1, 2021 | | |
January
2022 | | |
Q1
2023 | |
Vesting period | |
| 2
years | | |
| 2
years | | |
| 2-3
years | |
Expected
average volatility | |
| 187.7 | % | |
| 187.7 | % | |
| 187.7 | % |
Expected
dividend yield | |
| - | | |
| - | | |
| - | |
Common Stock Value | |
$ | 0.76 | | |
$ | 0.01-$0.08 | | |
$ | 0.02-$0.04 | |
Risk-free
interest rate | |
| 0.3 | % | |
| 1.81 | % | |
| 3.88%-3.39% | |
For
the three months ended March 31, 2023 and 2022 the company recognized expenses, to such options, in the amount of $279,000
and $252,000,
respectively. The expense is non-cash stock-based compensation expense resulting from options awards to our Chief Financial Officer
and advisors The expense represents the aggregate grant date fair value for the option awards granted and vested during the fiscal
years presented, determined in accordance with FASB ASC Topic 718.
APPYEA
INC.
NOTES
TO THE FINANCIAL STATEMENTS
|